A recent medical advancement in combating pancreatic cancer offers hopeful outcomes. This comes after years of dedicated research. The focus is on an experimental drug administered daily. This medication aims to extend patients’ lifespans by decelerating the disease’s progression.
Dr. Rachna Shroff plays a pivotal role in this development. As the Associate Director of Clinical Investigations at the University of Arizona Comprehensive Cancer Center, she provides crucial insights into the study’s findings and implications.
Stephanie Sy provides a platform for this discussion. Her role as a correspondent for PBS News Hour allows her to bring such stories to a wider audience. Over her career, Sy has held various positions, including roles at ABC News, Al Jazeera America, and CNN International. Her experience includes anchoring significant events, like the 2018 Midterm Elections, for Yahoo News.
Mount Sinai Health System Faces Subpoena on Gender-related Care 
Potential Ebola Outbreak in Central Africa Raises Concerns of Rapid Spread 
Researchers Escorted Out of Diabetes Conference for Criticizing Trump Administration 
Ebola Outbreak in Africa: A Serious Concern 
Gold and the Ebola Outbreak in Congo’s Mining Towns 
House Passes Bill for Veterans’ Benefit Increase